Aktiespot

Rohto Pharmaceutical Co.,Ltd. (ROHTO PHARMACEUTICAL CO) aktie

4527.T

Stängt
¥2,400.00+50.50 (+2.15%)
Laddar diagram...

ROHTO PHARMACEUTICAL CO

Öppning2,396.50
Högsta2,418.50
Lägsta2,391.50
Volym832.8k
P/E16.53
Börsvärde542.31B
52 veckors högsta2,703.00
52 veckors lägsta1,964.50
Genomsnittlig volym801.44k
Utdelning2.08%
Beta-0.46
EPS145.20

Om Rohto Pharmaceutical Co.,Ltd. (ROHTO PHARMACEUTICAL CO) aktie

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.

Företagsinformation

Börs: Tokyo (JPX)
Sektor: Stabile forbrugsvarer
Industri: Husholdnings- og personlige plejeprodukter
Adress:
1-8-1 Tatsuminishi
544-8666 Osaka, Japan
Telefon: + 81 6 6758 1231

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Anbefaling:1.91 - Køb
Lägsta kursmål
2,500.00
4.2%
Genomsnittligt kursmål
2,982.73
24.3%
Median kursmål
2,980.00
24.2%
Högsta kursmål
3,400.00
41.7%

Andra tittar också på: